NIKA Nika Pharmaceuticals, Inc.

Fundamentals / CIK 0001145604 / USD

Nika Pharmaceuticals, Inc. reported $5.3K in total assets and a net loss of $83K through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NIKA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$2.98MFY 2020 Net Income: -$8.9K2020FY 2021 Revenue: $0FY 2021 Net Income: -$15K2021FY 2022 Revenue: $0FY 2022 Net Income: -$3.18M2022FY 2023 Revenue: $0FY 2023 Net Income: -$65K2023FY 2024 Revenue: $0FY 2024 Net Income: -$96K2024FY 2025 Net Income: -$76K2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- $0 $0 $0 $0 --
Total Operating Expenses $76K $96K $65K $3.18M $15K $8.9K
Operating Income -$76K -$96K -$65K -$3.18M -$15K -$8.9K
Income Before Tax -$76K -$96K -$65K -$3.18M -$15K -$8.9K
Net Income -$76K -$96K -$65K -$3.18M -$15K -$8.9K
Basic EPS $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Diluted EPS $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Basic Shares Outstanding 1.05B 1.02B 876.1M 724.0M 396.1M 13.2M
Diluted Shares Outstanding 1.05B 1.02B 876.1M 724.0M 396.1M 13.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Total Operating Expenses $13K $20K $13K $37K $8.0K $18K $13K $12K
Operating Income -$13K -$20K -$13K -$37K -$8.0K -$18K -$13K -$12K
Income Before Tax -$13K -$20K -$13K -$37K -$8.0K -$18K -$13K -$12K
Net Income -$13K -$20K -$13K -$37K -$8.0K -$18K -$13K -$12K
Basic EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Diluted EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Basic Shares Outstanding 1.05B 1.05B 1.05B -- 1.04B 1.03B 1.03B --
Diluted Shares Outstanding 1.05B 1.05B 1.05B -- 1.04B 1.03B 1.03B --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.9K $2.1K $20K $864 $399 $1.6K
Cash & Short-Term Investments $1.9K $2.1K $20K $864 $399 $1.6K
Total Current Assets $21K $18K $20K $864 $399 $1.6K
Total Non-Current Assets $0 $0 $0 $0 $0 $0
Total Assets $21K $18K $20K $864 $399 $1.6K
Short-Term Debt $319K $239K $102K $18K -- --
Total Current Liabilities $319K $239K $102K $18K $11K --
Total Non-Current Liabilities $0 $0 $0 $0 $14K --
Total Liabilities $319K $239K $102K $18K $24K $11K
Total Debt (incl. Leases) $319K $239K $102K $18K -- --
Common Stock $105K $102K $88K $88K $40K $13K
Retained Earnings -$9.00M -$8.93M -$3.40M -$3.34M $152K $137K
Accumulated Other Comp. Income -- -- -- -- -- $137K
Total Stockholders' Equity -$298K -$221K -$82K -$17K -$24K -$8.9K
Total Equity -$298K -$221K -$82K -$17K -$24K -$8.9K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $352 $2.9K $1.5K $1.9K $6.3K $16K $19K $2.1K
Cash & Short-Term Investments $352 $2.9K $1.5K $1.9K $6.3K $16K $19K $2.1K
Total Current Assets $5.3K $9.9K $21K $21K $24K $32K $35K $18K
Total Non-Current Assets $0 $0 $0 $0 $0 $0 $0 $0
Total Assets $5.3K $9.9K $21K $21K $24K $32K $35K $18K
Short-Term Debt $349K $341K $332K $319K $284K $284K $269K $239K
Total Current Liabilities $349K $341K $332K $319K $284K $284K $269K $239K
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $349K $341K $332K $319K $284K $284K $269K $239K
Total Debt (incl. Leases) $349K $341K $332K $319K $284K $284K $269K $239K
Common Stock $105K $105K $105K $105K $104K $103K $103K $102K
Retained Earnings -$9.05M -$9.04M -$9.02M -$9.00M -$8.97M -$8.96M -$8.94M -$8.93M
Total Stockholders' Equity -$344K -$331K -$311K -$298K -$261K -$253K -$234K -$221K
Total Equity -$344K -$331K -$311K -$298K -$261K -$253K -$234K -$221K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$76K -$96K -$65K -$3.18M $15K -$8.9K
Change in Working Capital -- -- -- -- -$10K --
Operating Cash Flow -$80K -$155K -$65K $34K $15K -$8.9K
Common Stock Issued -- -- -- $10K -- --
Financing Cash Flow $79K $137K $84K $34K $14K $11K
Net Change in Cash -$194 -$18K $19K $465 -$1.2K $1.6K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$13K -$20K -$13K -$37K -$8.0K -$18K -$13K -$12K
Operating Cash Flow -$11K -$7.6K -$13K -$39K -$9.3K -$19K -$13K -$28K
Financing Cash Flow $8.4K $9.0K $13K $34K $0 $15K $30K $29K
Net Change in Cash -$2.6K $1.4K -$359 -$4.4K -$9.3K $31K -$17K $697

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Assets (ROA) -363.9% -534.1% -330.8% -368485.5% -3687.2% -552.9%
Current Ratio 0.07x 0.07x 0.19x 0.05x 0.04x --
Quick Ratio 0.01x 0.01x 0.19x 0.05x 0.04x --
Operating Cash Flow Growth (YoY) -- -- -292.3% +129.2% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Assets (ROA) -1566.5% -785.8% -372.2% -363.9% -219.1% -165.0% -160.7% -497.5%
Current Ratio 0.02x 0.03x 0.06x 0.07x 0.08x 0.11x 0.13x 0.07x
Quick Ratio 0.00x 0.01x 0.00x 0.01x 0.02x 0.05x 0.07x 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001145604) · from September 30, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:38 UTC · Open in terminal